PATENT CLAIM ANALYSIS

Application Number: 15949155
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["540", "456000"]

Abstract:
The present invention pertains to a method for screening a compound useful in reducing astroglial edema, said method comprising: (i) providing a compound; (ii) bringing said compound in contact with an astrocyte; and (iii) determining the cAMP level in said astrocyte contacted with said compound; wherein said compound is identified as a compound useful in reducing astroglial edema, if the cAMP level in the astocyte increases after contact. The present invention further pertains to an agent elevating the cAMP level in astrocytes for use in reducing astroglial edema.

Claim (Index 3):
The method according to  claim 1 , wherein said agonist for a \u03b2-adrenergic receptor (\u03b2-AR) is adrenaline (ADR).

Metadata:
- Claim Count in Document: 16.0
- Percentile: 91.0
- Lexical Diversity: 2.0
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14900656', '11586707', '10538985', '15331372', '11322648']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6484958225864775
- 35 USC 102 Novelty (BERT): 0.6212760287947243
- Combined Prediction Score: 0.6457738432073021
- Mean Citation Score: 336.13291
- Max Citation Score: 811.08417
- Similarity Product: 464.2752418226498

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test